PDGF is Required for Remyelination-Promoting IgM Stimulation of Oligodendrocyte Progenitor Cell Proliferation

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Watzlawik, Jens O ^a   Warrington, Arthur E ^a   Rodriguez, Moses ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; FIBROBLAST GROWTH FACTOR 2; GLIAL FIBRILLARY ACIDIC PROTEIN; KI 67 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCLONAL ANTIBODY; OLIG1 PROTEIN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN KINASE FYN; PROTEIN KINASE LYN; PROTEIN KINASE P60; RECOMBINANT HUMAN MONOCLONAL IMMUNOGLOBULIN M 22; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INTRACELLULAR SIGNALING; LYMPHOCYTE ACTIVATION; NERVE CELL DIFFERENTIATION; NERVE CELL STIMULATION; NEURAL STEM CELL; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REMYELINIZATION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; BROMODEOXYURIDINE; CELL PROLIFERATION; HUMANS; IMMUNOGLOBULIN M; IMMUNOHISTOCHEMISTRY; MICROSCOPY, FLUORESCENCE; MULTIPLE SCLEROSIS; MYELIN SHEATH; OLIGODENDROGLIA; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, SPRAGUE-DAWLEY; STEM CELLS; THYMIDINE;

EID: 84873248664     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055149     Document Type: Article

References (92)

1. Blakemore WF, (1984) Limited remyelination of CNS axons by Schwann cells transplanted into the sub-arachnoid space. J Neurol Sci 64: 265-276.
2. Blakemore WF, Crang AJ, (1985) The use of cultured autologous Schwann cells to remyelinate areas of persistent demyelination in the central nervous system. J Neurol Sci 70: 207-223.
3. Brustle O, Jones KN, Learish RD, Karram K, Choudhary K, et al. (1999) Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science 285: 754-756.
4. Groves AK, Barnett SC, Franklin RJ, Crang AJ, Mayer M, et al. (1993) Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells. Nature 362: 453-455.
5. Hammang JP, Archer DR, Duncan ID, (1997) Myelination following transplantation of EGF-responsive neural stem cells into a myelin-deficient environment. Exp Neurol 147: 84-95.
6. Honmou O, Felts PA, Waxman SG, Kocsis JD, (1996) Restoration of normal conduction properties in demyelinated spinal cord axons in the adult rat by transplantation of exogenous Schwann cells. J Neurosci 16: 3199-3208.
7. Windrem MS, Nunes MC, Rashbaum WK, Schwartz TH, Goodman RA, et al. (2004) Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat Med 10: 93-97.
8. Windrem MS, Roy NS, Wang J, Nunes M, Benraiss A, et al. (2002) Progenitor cells derived from the adult human subcortical white matter disperse and differentiate as oligodendrocytes within demyelinated lesions of the rat brain. J Neurosci Res 69: 966-975.
9. Mi S, Lee X, Shao Z, Thill G, Ji B, et al. (2004) LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci 7: 221-228.
10. Mi S, Miller RH, Lee X, Scott ML, Shulag-Morskaya S, et al. (2005) LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci 8: 745-751.
11. Mi S, Miller RH, Tang W, Lee X, Hu B, et al. (2009) Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Ann Neurol 65: 304-315.
12. Mi S, Hu B, Hahm K, Luo Y, Kam Hui ES, et al. (2007) LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat Med 13: 1228-1233.
13. Asakura K, Miller DJ, Murray K, Bansal R, Pfeiffer SE, et al. (1996) Monoclonal autoantibody SCH94.03, which promotes central nervous system remyelination, recognizes an antigen on the surface of oligodendrocytes. J Neurosci Res 43: 273-281.
14. Asakura K, Pogulis RJ, Pease LR, Rodriguez M, (1996) A monoclonal autoantibody which promotes central nervous system remyelination is highly polyreactive to multiple known and novel antigens. J Neuroimmunol 65: 11-19.
15. Bieber AJ, Warrington A, Asakura K, Ciric B, Kaveri SV, et al. (2002) Human antibodies accelerate the rate of remyelination following lysolecithin-induced demyelination in mice. Glia 37: 241-249.
16. Miller DJ, Sanborn KS, Katzmann JA, Rodriguez M, (1994) Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis. J Neurosci 14: 6230-6238.
17. Pavelko KD, van Engelen BG, Rodriguez M, (1998) Acceleration in the rate of CNS remyelination in lysolecithin-induced demyelination. J Neurosci 18: 2498-2505.
18. Warrington AE, Asakura K, Bieber AJ, Ciric B, Van Keulen V, et al. (2000) Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc Natl Acad Sci U S A 97: 6820-6825.
19. Warrington AE, Bieber AJ, Ciric B, Pease LR, Van Keulen V, et al. (2007) A recombinant human IgM promotes myelin repair after a single, very low dose. J Neurosci Res 85: 967-976.
20. Paz Soldan MM, Warrington AE, Bieber AJ, Ciric B, Van Keulen V, et al. (2003) Remyelination-promoting antibodies activate distinct Ca2+ influx pathways in astrocytes and oligodendrocytes: relationship to the mechanism of myelin repair. Mol Cell Neurosci 22: 14-24.
21. Asakura K, Miller DJ, Pease LR, Rodriguez M, (1998) Targeting of IgMkappa antibodies to oligodendrocytes promotes CNS remyelination. J Neurosci 18: 7700-7708.
22. Stangel M, Bernard D, (2003) Polyclonal IgM influence oligodendrocyte precursor cells in mixed glial cell cultures: implications for remyelination. J Neuroimmunol 138: 25-30.
23. Bansal R, Winkler S, Bheddah S, (1999) Negative regulation of oligodendrocyte differentiation by galactosphingolipids. J Neurosci 19: 7913-7924.
24. Watzlawik J, Holicky E, Edberg DD, Marks DL, Warrington AE, et al. (2010) Human remyelination promoting antibody inhibits apoptotic signaling and differentiation through Lyn kinase in primary rat oligodendrocytes. Glia 58: 1782-1793.
25. Chudakova DA, Zeidan YH, Wheeler BW, Yu J, Novgorodov SA, et al. (2008) Integrin-associated Lyn kinase promotes cell survival by suppressing acid sphingomyelinase activity. J Biol Chem 283: 28806-28816.
26. Baron W, Colognato H, ffrench-Constant C, (2005) Integrin-growth factor interactions as regulators of oligodendroglial development and function. Glia 49: 467-479.
27. Colognato H, Ramachandrappa S, Olsen IM, ffrench-Constant C, (2004) Integrins direct Src family kinases to regulate distinct phases of oligodendrocyte development. J Cell Biol 167: 365-375.
28. Decker L, Baron W, Ffrench-Constant C, (2004) Lipid rafts: microenvironments for integrin-growth factor interactions in neural development. Biochem Soc Trans 32: 426-430.
29. Hart IK, Richardson WD, Heldin CH, Westermark B, Raff MC, (1989) PDGF receptors on cells of the oligodendrocyte-type-2 astrocyte (O-2A) cell lineage. Development 105: 595-603.
30. Fruttiger M, Calver AR, Kruger WH, Mudhar HS, Michalovich D, et al. (1996) PDGF mediates a neuron-astrocyte interaction in the developing retina. Neuron 17: 1117-1131.
31. Fruttiger M, Calver AR, Richardson WD, (2000) Platelet-derived growth factor is constitutively secreted from neuronal cell bodies but not from axons. Curr Biol 10: 1283-1286.
32. Pringle N, Collarini EJ, Mosley MJ, Heldin CH, Westermark B, et al. (1989) PDGF A chain homodimers drive proliferation of bipotential (O-2A) glial progenitor cells in the developing rat optic nerve. Embo J 8: 1049-1056.
33. Silberstein FC, De Simone R, Levi G, Aloisi F, (1996) Cytokine-regulated expression of platelet-derived growth factor gene and protein in cultured human astrocytes. J Neurochem 66: 1409-1417.
34. Calver AR, Hall AC, Yu WP, Walsh FS, Heath JK, et al. (1998) Oligodendrocyte population dynamics and the role of PDGF in vivo. Neuron 20: 869-882.
35. Fruttiger M, Karlsson L, Hall AC, Abramsson A, Calver AR, et al. (1999) Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice. Development 126: 457-467.
36. Noble M, Murray K, Stroobant P, Waterfield MD, Riddle P, (1988) Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature 333: 560-562.
37. Raff MC, Lillien LE, Richardson WD, Burne JF, Noble MD, (1988) Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature 333: 562-565.
38. Richardson WD, Pringle N, Mosley MJ, Westermark B, Dubois-Dalcq M, (1988) A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell 53: 309-319.
39. Barres BA, Hart IK, Coles HS, Burne JF, Voyvodic JT, et al. (1992) Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70: 31-46.
40. Barres BA, Schmid R, Sendnter M, Raff MC, (1993) Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118: 283-295.
41. Bogler O, Wren D, Barnett SC, Land H, Noble M, (1990) Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc Natl Acad Sci U S A 87: 6368-6372.
42. McKinnon RD, Matsui T, Dubois-Dalcq M, Aaronson SA, (1990) FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron 5: 603-614.
43. Milner R, Anderson HJ, Rippon RF, McKay JS, Franklin RJ, et al. (1997) Contrasting effects of mitogenic growth factors on oligodendrocyte precursor cell migration. Glia 19: 85-90.
44. Osterhout DJ, Ebner S, Xu J, Ornitz DM, Zazanis GA, et al. (1997) Transplanted oligodendrocyte progenitor cells expressing a dominant-negative FGF receptor transgene fail to migrate in vivo. J Neurosci 17: 9122-9132.
45. Bansal R, Pfeiffer SE, (1994) Inhibition of protein and lipid sulfation in oligodendrocytes blocks biological responses to FGF-2 and retards cytoarchitectural maturation, but not developmental lineage progression. Dev Biol 162: 511-524.
46. Bansal R, Pfeiffer SE, (1997) Regulation of oligodendrocyte differentiation by fibroblast growth factors. Adv Exp Med Biol 429: 69-77.
47. Gard AL, Pfeiffer SE, (1993) Glial cell mitogens bFGF and PDGF differentially regulate development of O4+GalC- oligodendrocyte progenitors. Dev Biol 159: 618-630.
48. Mayer M, Bogler O, Noble M, (1993) The inhibition of oligodendrocytic differentiation of O-2A progenitors caused by basic fibroblast growth factor is overridden by astrocytes. Glia 8: 12-19.
49. Pettmann B, Labourdette G, Weibel M, Sensenbrenner M, (1986) The brain fibroblast growth factor (FGF) is localized in neurons. Neurosci Lett 68: 175-180.
50. Ferrara N, Ousley F, Gospodarowicz D, (1988) Bovine brain astrocytes express basic fibroblast growth factor, a neurotropic and angiogenic mitogen. Brain Res 462: 223-232.
51. Hatten ME, Lynch M, Rydel RE, Sanchez J, Joseph-Silverstein J, et al. (1988) In vitro neurite extension by granule neurons is dependent upon astroglial-derived fibroblast growth factor. Dev Biol 125: 280-289.
52. Araujo DM, Cotman CW, (1992) Basic FGF in astroglial, microglial, and neuronal cultures: characterization of binding sites and modulation of release by lymphokines and trophic factors. J Neurosci 12: 1668-1678.
53. Presta M, Urbinati C, Dell'era P, Lauro GM, Sogos V, et al. (1995) Expression of basic fibroblast growth factor and its receptors in human fetal microglia cells. Int J Dev Neurosci 13: 29-39.
54. Shimojo M, Nakajima K, Takei N, Hamanoue M, Kohsaka S, (1991) Production of basic fibroblast growth factor in cultured rat brain microglia. Neurosci Lett 123: 229-231.
55. Bansal R, Kumar M, Murray K, Morrison RS, Pfeiffer SE, (1996) Regulation of FGF receptors in the oligodendrocyte lineage. Mol Cell Neurosci 7: 263-275.
56. Bansal R, Pfeiffer SE, (1997) FGF-2 converts mature oligodendrocytes to a novel phenotype. J Neurosci Res 50: 215-228.
57. Balaci L, Presta M, Ennas MG, Dell'Era P, Sogos V, et al. (1994) Differential expression of fibroblast growth factor receptors by human neurones, astrocytes and microglia. Neuroreport 6: 197-200.
58. McCarthy KD, de Vellis J, (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85: 890-902.
59. Bottenstein JE, (1986) Growth requirements in vitro of oligodendrocyte cell lines and neonatal rat brain oligodendrocytes. Proc Natl Acad Sci U S A 83: 1955-1959.
60. Sharma DK, Brown JC, Cheng Z, Holicky EL, Marks DL, et al. (2005) The glycosphingolipid, lactosylceramide, regulates beta1-integrin clustering and endocytosis. Cancer Res 65: 8233-8241.
61. Bansal R, Magge S, Winkler S, (2003) Specific inhibitor of FGF receptor signaling: FGF-2-mediated effects on proliferation, differentiation, and MAPK activation are inhibited by PD173074 in oligodendrocyte-lineage cells. J Neurosci Res 74: 486-493.
62. Baron W, Metz B, Bansal R, Hoekstra D, de Vries H, (2000) PDGF and FGF-2 signaling in oligodendrocyte progenitor cells: regulation of proliferation and differentiation by multiple intracellular signaling pathways. Mol Cell Neurosci 15: 314-329.
63. Becker-Catania SG, Nelson JK, Olivares S, Chen SJ, DeVries GH Oligodendrocyte progenitor cells proliferate and survive in an immature state following treatment with an axolemma-enriched fraction. ASN Neuro 3: e00053.
64. Heldin CH, Ostman A, Ronnstrand L, (1998) Signal transduction via platelet-derived growth factor receptors. Biochim Biophys Acta 1378: F79-113.
65. Fantl WJ, Escobedo JA, Williams LT, (1989) Mutations of the platelet-derived growth factor receptor that cause a loss of ligand-induced conformational change, subtle changes in kinase activity, and impaired ability to stimulate DNA synthesis. Mol Cell Biol 9: 4473-4478.
66. Kazlauskas A, Cooper JA, (1989) Autophosphorylation of the PDGF receptor in the kinase insert region regulates interactions with cell proteins. Cell 58: 1121-1133.
67. Yim SH, Hammer JA, Quarles RH, (2001) Differences in signal transduction pathways by which platelet-derived and fibroblast growth factors activate extracellular signal-regulated kinase in differentiating oligodendrocytes. J Neurochem 76: 1925-1934.
68. Sperber BR, Boyle-Walsh EA, Engleka MJ, Gadue P, Peterson AC, et al. (2001) A unique role for Fyn in CNS myelination. J Neurosci 21: 2039-2047.
69. Thomas SM, Brugge JS, (1997) Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 13: 513-609.
70. Umemori H, Wanaka A, Kato H, Takeuchi M, Tohyama M, et al. (1992) Specific expressions of Fyn and Lyn, lymphocyte antigen receptor-associated tyrosine kinases, in the central nervous system. Brain Res Mol Brain Res 16: 303-310.
71. Gamas P, Marchetti S, Puissant A, Grosso S, Jacquel A, et al. (2009) Inhibition of imatinib-mediated apoptosis by the caspase-cleaved form of the tyrosine kinase Lyn in chronic myelogenous leukemia cells. Leukemia 23: 1500-1506.
72. Grishin AV, Azhipa O, Semenov I, Corey SJ, (2001) Interaction between growth arrest-DNA damage protein 34 and Src kinase Lyn negatively regulates genotoxic apoptosis. Proc Natl Acad Sci U S A 98: 10172-10177.
73. Guan H, Zhou Z, Gallick GE, Jia SF, Morales J, et al. (2008) Targeting Lyn inhibits tumor growth and metastasis in Ewing's sarcoma. Mol Cancer Ther 7: 1807-1816.
74. Luciano F, Herrant M, Jacquel A, Ricci JE, Auberger P, (2003) The p54 cleaved form of the tyrosine kinase Lyn generated by caspases during BCR-induced cell death in B lymphoma acts as a negative regulator of apoptosis. Faseb J 17: 711-713.
75. Wei S, Liu JH, Epling-Burnette PK, Gamero AM, Ussery D, et al. (1996) Critical role of Lyn kinase in inhibition of neutrophil apoptosis by granulocyte-macrophage colony-stimulating factor. J Immunol 157: 5155-5162.
76. Pirko I, Ciric B, Gamez J, Bieber AJ, Warrington AE, et al. (2004) A human antibody that promotes remyelination enters the CNS and decreases lesion load as detected by T2-weighted spinal cord MRI in a virus-induced murine model of MS. Faseb J 18: 1577-1579.
77. Carroll WM, Jennings AR, (1994) Early recruitment of oligodendrocyte precursors in CNS demyelination. Brain 117 (Pt 3): 563-578.
78. Gensert JM, Goldman JE, (1997) Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron 19: 197-203.
79. Horner PJ, Power AE, Kempermann G, Kuhn HG, Palmer TD, et al. (2000) Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J Neurosci 20: 2218-2228.
80. Watanabe M, Toyama Y, Nishiyama A, (2002) Differentiation of proliferated NG2-positive glial progenitor cells in a remyelinating lesion. J Neurosci Res 69: 826-836.
81. Zhang SC, Ge B, Duncan ID, (1999) Adult brain retains the potential to generate oligodendroglial progenitors with extensive myelination capacity. Proc Natl Acad Sci U S A 96: 4089-4094.
82. Pul R, Nguyen D, Schmitz U, Marx P, Stangel M, (2002) Comparison of intravenous immunoglobulin preparations on microglial function in vitro: more potent immunomodulatory capacity of an IgM/IgA-enriched preparation. Clin Neuropharmacol 25: 254-259.
83. van Heyningen P, Calver AR, Richardson WD, (2001) Control of progenitor cell number by mitogen supply and demand. Curr Biol 11: 232-241.
84. Baron W, Shattil SJ, ffrench-Constant C, (2002) The oligodendrocyte precursor mitogen PDGF stimulates proliferation by activation of alpha(v)beta3 integrins. Embo J 21: 1957-1966.
85. Colognato H, Baron W, Avellana-Adalid V, Relvas JB, Baron-Van Evercooren A, et al. (2002) CNS integrins switch growth factor signalling to promote target-dependent survival. Nat Cell Biol 4: 833-841.
86. Frost EE, Buttery PC, Milner R, ffrench-Constant C, (1999) Integrins mediate a neuronal survival signal for oligodendrocytes. Curr Biol 9: 1251-1254.
87. Redwine JM, Armstrong RC, (1998) In vivo proliferation of oligodendrocyte progenitors expressing PDGFalphaR during early remyelination. J Neurobiol 37: 413-428.
88. Vana AC, Flint NC, Harwood NE, Le TQ, Fruttiger M, et al. (2007) Platelet-derived growth factor promotes repair of chronically demyelinated white matter. J Neuropathol Exp Neurol 66: 975-988.
89. Barres BA, Raff MC, Gaese F, Bartke I, Dechant G, et al. (1994) A crucial role for neurotrophin-3 in oligodendrocyte development. Nature 367: 371-375.
90. Jiang F, Frederick TJ, Wood TL, (2001) IGF-I synergizes with FGF-2 to stimulate oligodendrocyte progenitor entry into the cell cycle. Dev Biol 232: 414-423.
91. Robinson S, Tani M, Strieter RM, Ransohoff RM, Miller RH, (1998) The chemokine growth-regulated oncogene-alpha promotes spinal cord oligodendrocyte precursor proliferation. J Neurosci 18: 10457-10463.
92. Canoll PD, Musacchio JM, Hardy R, Reynolds R, Marchionni MA, et al. (1996) GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors. Neuron 17: 229-243.